Lipids and Surfactants: The Inside Story of Lipid-Based Drug Delivery Systems

Abstract

In the bioavailability enhancement of poorly aqueous soluble drugs, self-emulsifying/microemulsifying drug delivery systems (SEDDS/SMEDDS) are isotropic mixtures of oils, surfactants, solvents, and cosolvents/surfactants that have gained immense popularity because of their self-emulsification ability. This characteristic relies on some critical parameters such as surfactant concentration, oil-to-surfactant ratio, polarity of the emulsion, droplet size and charge, which are acquired from an amalgamation of appropriate excipients. The fabrication of this combination is of utmost importance for formulation scientists. Hence, to explore the potential of such a delivery system, standardized guidelines for excipients must be developed to address bioavailability issues. In the present review, we summarize the approaches to selecting the most suitable lipid(s)-based drug delivery system, including characterization, especially for oral delivery, of both physicochemical and biopharmaceutical aspects and properties of assorted excipients as well as the related patent reports.

Snedds as Lipid-Based Nanocarrier Systems: Concepts and Formulation Insights

“…Nanocarriers provide several advantages, such as preventing active drugs from degrading, allowing for higher and more efficient concentrations in the target tissue, and reducing the severity of toxic side effects [16]. The lipid-based nanocarriers have greater importance due to their low toxicity [17], high drug-loading capacity [18], improved bioavailability [19], high biocompatibility [20], high protection from degradation in the gastrointestinal tract (GIT [21], controlled-release behavior [3], ease to scale-up and sterilize [6], easy to validate [2], and also useful for the administration of drugs through different routes [17]. Unique properties like, tailorable surface to apply any targeting strategy, and an improved bio distribution and pharmacokinetic profile makes lipid-based system as a unique approach.…”

“…Unique properties like, tailorable surface to apply any targeting strategy, and an improved bio distribution and pharmacokinetic profile makes lipid-based system as a unique approach. Lipid nanocarriers are developed by using various types of biodegradable and biocompatible materials [20].…”

“…Pouton and Porter introduced the lipid classification system [6] based on the type and amount of excipients [1] used and by considering the morphology of lipid aggregates [3]. This classification helps in the selection of lipids based on their properties in formulation development [20]. As per their classification, the LBFCS are divided into four types.…”

Enhanced Bioavailability of Dihydrotanshinone I–Bovine Serum Albumin Nanoparticles for Stroke Therapy

“…In many laboratory research studies, the inorganic mesoporous nanomaterials were also used to load the hydrophobic drugs, which can not only provide a solubility enhancement of the drugs but also control the drug release rate (Zhang et al, 2019;Lin et al, 2021). However, the pharmacokinetics and elimination pathways of these exogenous chemicals are difficult to control, thereby leading to the drug additive-related toxicity, which may further cause adverse side effects of the bodies such as irritation or allergy (Souney et al, 2010;Pandey and Kohli, 2018;Dai et al, 2021).…”

Novel surfactant stabilized PLGA cisplatin nanoparticles for drug delivery applications

“…From detergents to cosmetics, surfactants come in handy for human use in every possible way. Their surface-active properties and the tendency to alter surface tension of the medium make them a unique and diversely applicable class of compounds [4][5][6].…”